Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

BACKGROUND: E1697 was a phase III trial of adjuvant interferon (IFN)-α2b for one month (Arm B) versus observation (Arm A) in patients with resected melanoma at intermediate risk. We evaluated the levels of candidate serum cytokines, the HLA genotype, polymorphisms of CTLA4 and FOXP3 genes and the de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Tarhini, Ahmad A., Lin, Yan, Zahoor, Haris, Shuai, Yongli, Butterfield, Lisa H., Ringquist, Steven, Gogas, Helen, Sander, Cindy, Lee, Sandra, Agarwala, Sanjiv S., Kirwood, John M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508028/
https://ncbi.nlm.nih.gov/pubmed/26192408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0132745
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky